Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization | PLOS Medicine
![Figure 1 from CO2 laser cryptolysis by coagulation for the treatment of halitosis. | Semantic Scholar Figure 1 from CO2 laser cryptolysis by coagulation for the treatment of halitosis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b528dc4bdff24fbd633cd3bd82c9599de3142517/2-Figure1-1.png)
Figure 1 from CO2 laser cryptolysis by coagulation for the treatment of halitosis. | Semantic Scholar
![Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry (LCM-LC/MS) | Protocol Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry (LCM-LC/MS) | Protocol](https://cloudfront.jove.com/files/ftp_upload/57402/57402fig3.jpg)
Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry (LCM-LC/MS) | Protocol
![Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry (LCM-LC/MS). - Abstract - Europe PMC Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry (LCM-LC/MS). - Abstract - Europe PMC](https://cloudflare.jove.com/files/ftp_upload/57402/57402fig2large.jpg)